AU4665196A - Eukaryotic initiation factor 5A (eIF-5A) mutants - Google Patents

Eukaryotic initiation factor 5A (eIF-5A) mutants

Info

Publication number
AU4665196A
AU4665196A AU46651/96A AU4665196A AU4665196A AU 4665196 A AU4665196 A AU 4665196A AU 46651/96 A AU46651/96 A AU 46651/96A AU 4665196 A AU4665196 A AU 4665196A AU 4665196 A AU4665196 A AU 4665196A
Authority
AU
Australia
Prior art keywords
eif
mutants
initiation factor
eukaryotic initiation
eukaryotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46651/96A
Other languages
English (en)
Inventor
Joachim Hauber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9502771.0A external-priority patent/GB9502771D0/en
Priority claimed from GBGB9513505.9A external-priority patent/GB9513505D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4665196A publication Critical patent/AU4665196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU46651/96A 1995-02-13 1996-02-12 Eukaryotic initiation factor 5A (eIF-5A) mutants Abandoned AU4665196A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9502771.0A GB9502771D0 (en) 1995-02-13 1995-02-13 Organic compounds
GB9502771 1995-02-13
GB9513505 1995-07-03
GBGB9513505.9A GB9513505D0 (en) 1995-07-03 1995-07-03 Organic compounds
PCT/EP1996/000585 WO1996025492A1 (en) 1995-02-13 1996-02-12 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS

Publications (1)

Publication Number Publication Date
AU4665196A true AU4665196A (en) 1996-09-04

Family

ID=26306494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46651/96A Abandoned AU4665196A (en) 1995-02-13 1996-02-12 Eukaryotic initiation factor 5A (eIF-5A) mutants

Country Status (15)

Country Link
EP (1) EP0811060A1 (fi)
JP (1) JPH10509327A (fi)
KR (1) KR19980702160A (fi)
CN (1) CN1173897A (fi)
AU (1) AU4665196A (fi)
BR (1) BR9606951A (fi)
CA (1) CA2210538A1 (fi)
CZ (1) CZ255397A3 (fi)
FI (1) FI972763A (fi)
HU (1) HUP9801681A3 (fi)
IL (1) IL117113A0 (fi)
NO (1) NO973679L (fi)
PL (1) PL321239A1 (fi)
SK (1) SK109997A3 (fi)
WO (1) WO1996025492A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002079A2 (en) * 1997-06-30 2000-05-24 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Novel inhibitor of cellular proliferation
US7968523B2 (en) * 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US7381708B2 (en) 2001-07-23 2008-06-03 Sensco Technologies, Inc. Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
US6867237B1 (en) * 2001-07-23 2005-03-15 Senesco Technologies, Inc. DNA encoding apoptosis-induced eucaryotic initiation factor-5A and deoxyhypusine synthase and a method for controlling apoptosis in animals and humans
EP1601767B1 (en) 2003-03-05 2012-04-25 Senesco Technologies, Inc. USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
AU2004258070B2 (en) * 2003-06-06 2008-12-11 Senesco Technologies, Inc. Inhibition of apoptosis-specific elF-5A ("elF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics
CN102282259A (zh) 2008-03-07 2011-12-14 森尼斯科技术公司 与有义构建体实现期望多核苷酸的表达的用途相组合的、sirna实现内源基因的减量调节的用途
US8445638B2 (en) 2008-09-03 2013-05-21 Senesco Technologies, Inc. Use of a truncated eIF-5A1 polynucleotide to induce apoptosis in cancer cells

Also Published As

Publication number Publication date
MX9705757A (es) 1998-07-31
SK109997A3 (en) 1998-04-08
PL321239A1 (en) 1997-11-24
CA2210538A1 (en) 1996-08-22
JPH10509327A (ja) 1998-09-14
NO973679L (no) 1997-10-13
HUP9801681A3 (en) 2000-10-30
BR9606951A (pt) 1997-10-28
WO1996025492A1 (en) 1996-08-22
IL117113A0 (en) 1996-06-18
NO973679D0 (no) 1997-08-11
EP0811060A1 (en) 1997-12-10
FI972763A0 (fi) 1997-06-26
FI972763A (fi) 1997-10-10
HUP9801681A2 (hu) 1998-10-28
CZ255397A3 (cs) 1998-02-18
CN1173897A (zh) 1998-02-18
KR19980702160A (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
AU5917796A (en) Streptavidin mutants
AU5370296A (en) Electrolyte materials containing highly dissociated metal ionsalts
AU5302598A (en) Tilting means
AU5451596A (en) Snips
AU7074394A (en) Separation method
AUPN426595A0 (en) Firearms
AU6304196A (en) Substituted cyanophenyluracils
AU6549896A (en) Metal stitcher
AU5798494A (en) Lineare adhesionsinhibitoren
AU4665196A (en) Eukaryotic initiation factor 5A (eIF-5A) mutants
AU5492094A (en) Lighter
AU3385693A (en) Determination method
AU6008494A (en) Wedge
AU3093592A (en) Aluminium alloy
AU6304396A (en) Substituted carbonylaminophenyluracils
AU6411696A (en) Non-ball mill
AU7541796A (en) Compact rolling block
AU7436994A (en) Mirror
AU6658696A (en) Substituted phenyluracils
AU3535595A (en) Jet-vortex mill
AU1175297A (en) Metal section
AU1962795A (en) Lighter
AU6664296A (en) Aluminium alloy
AU5323096A (en) Substituted 6-azacholesten-3-ones
AU1138397A (en) Novel method

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted